James Kergon, head of deal advisory for KPMG in Scotland
James Kergon, head of deal advisory for KPMG in Scotland

Investment in Scottish companies doubles with healthcare leading the way

Scottish companies raised £42million in the third quarter of 2018 (July – September), more than double the amount raised in

Facebook
X
LinkedIn

Subscribe to our daily newsletter

Why? Free to subscribe, no paywall, daily business news digest.

Scottish companies raised £42million in the third quarter of 2018 (July – September), more than double the amount raised in the previous quarter (£21million).

New figures from KPMG’s Venture Pulse report, which highlights key trends, opportunities and challenges facing the venture capital market, also reveals £35.8million out of a total £42million was raised by businesses in Scotland’s healthcare sector.

[adbutler zone_id=’297765′]

Standout deals in Scotland included £18millon raised by Edinburgh-based DYSIS Medical, a developer of medical equipment, and £8.54million by Care Sourcer, a care provider comparison site.

The regional trend mirrors the UK-wide and global story, which saw healthcare and biotechnology driving some of the quarter’s top investment deals, including London-based gene therapy developer, Orchard Therapeutics (£112million), and drug developer Artois at £65million. Globally, healthcare companies raised £14.5billion ($19billion) in the third quarter of 2018.

In total, £1.4billion of Venture Capital was invested in UK businesses in the last three months, thanks to a number of multi-million pound deals.

James Kergon, head of deal advisory for KPMG in Scotland, said: “The summer is usually quite a quiet period for investment, yet Scotland has continued to attract investors, particularly in the healthcare sector.

“Scotland’s healthcare companies, both large and small are thriving, and as the UK’s population continues to grow older, drug development and biotechnology will continue to be a safe bet for investors.

“Start-ups fared particularly well, with early-stage financings accounting for £16million of investment, including a remote patient monitoring developer, Snap40, raising £6.1million in its seed round.

“This is particularly encouraging for Scotland as we prepare to leave the EU, and while investors will be keeping a close eye on negotiations in the coming months, shows confidence in Scotland’s economy and its ability to remain at the forefront of technological developments.”

[yikes-mailchimp form=”2″ title=”1″ description=”1″]

Facebook
X
LinkedIn

Related Articles

RoslinCT awarded Scottish Enterprise grant of up to £7.25m for digital manufacturing programme
Credit: Clarus Network
Clarus Networks receives King’s Award for Enterprise
M Core’s Sheet Anchor Evolve acquires East Kilbride shopping centre
Lab equipment reuse firm plans 120 jobs at former Dumfries DHL depot
Credit: ESP Group
ESP Group Shortlisted for WeDO Scotland High Growth Award
Henry Shulayev Barnes for Catalyst Neuromorphic (Credit: University of Aberdeen)
University of Aberdeen ventures win three national innovation awards

Other Articles from HGS

The Latest Stories